Workspace / Research/DIVISLAB
Prices to 11 Sept 2026 · Financials to 30 Jun 2026 · Developments 13 Sept 2026
Company research / Focus view

Divi's Laboratories

DIVISLAB · Pharma & Healthcare · large cap · Nifty Next 50

Revenue · FY26
₹10,476 cr
+12.3% YoY

What the business sold

Net profit · FY26
₹2,568 cr
+17.2% YoY

What it kept after tax

Operating profit · FY26
₹2,979 cr
+15.9% YoY

Profit from operations

Operating cash flow · FY26
₹2,738 cr
+65.6% YoY

Cash the operations produced

Total debt · FY26
₹7 cr
+75.0% YoY

Borrowings against the business

Dividend per share · FY26

Paid out per share · not collected yet

Five years in perspective

Price index · Start = 100 · Dividends excluded · ₹9,322 today (-1.23%)

+84.4% · 5Y
2021 · 10020222023202420252026 · 181.0
1M +8.7%6M +46.8%1Y +55.0%3Y +149.5%5Y +84.4%
Market cap
₹2.47 L Cr

As of 13 Sept 2026

Price to earnings
84.7

Price to book 14.8

Dividend yield
32.00%

Trailing twelve months

52-week range
₹5,637 – ₹9,615

Closing prices

Sign in to see the full financial record and classified developments

Guests see a sample. Members get every company, five-year fundamentals, classified developments, a watchlist and the decision journal.

Sign in with Google